Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.79% | 83.27 | 0.9% | $976.48m | |
| KITE | Kite Pharma, Inc. | -0.05% | 179.30 | 16.1% | $742.08m | |
| CELG | Celgene Corporation | 0.08% | 143.89 | 1.1% | $497.73m | |
| AMGN | Amgen Inc. | -0.47% | 185.76 | 1.1% | $483.16m | |
| BIIB | Biogen Inc. | 1.09% | 318.46 | 1.2% | $422.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.17% | 432.72 | 2.7% | $354.34m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.78% | 113.80 | 10.7% | $245.72m | |
| JUNO | Juno Therapeutics, Inc. | 8.46% | 45.14 | 14.6% | $236.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.07% | 142.82 | 1.9% | $228.97m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.53% | 151.26 | 1.9% | $211.37m | |
| INCY | Incyte Corporation | -3.65% | 110.85 | 2.6% | $207.65m | |
| ILMN | Illumina, Inc. | 0.58% | 201.41 | 3.5% | $159.41m | |
| BLUE | Bluebird Bio, Inc. | 0.70% | 128.75 | 19.3% | $141.45m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.64% | 94.95 | 4.4% | $137.39m | |
| CLVS | Clovis Oncology, Inc. | 2.09% | 78.56 | 18.0% | $136.44m |
Company Profile
Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO.